BridgeBio is substantially advanced its progress of the new solution for amyloid heart disease, leveraging Attruby. Preliminary trial data reveals promising improvements for patients affected from this severe disease. https://attr-cm931571.bloggactif.com/43636894/company-improves-cardiac-amyloidosis-therapy-using-the-therapy